Skip to main content
Premium Trial:

Request an Annual Quote

At Large Scale Biology, Old President Returns to Become CEO

NEW YORK, April 14 - Large Scale Biology has appointed Kevin Ryan as its new president and CEO, replacing its current CEO, Robert Erwin, and former president, John Fowler, the company said today.

 

Erwin, a founder of LSBC, will remain as chairman of the board and head of the company's scientific advisory board. Fowler, who resigned as president, will remain on the LSBC board of directors through the current term and will join private investment firm Baycrest Capital.

 

"The appointment of Mr. Ryan, an executive with an outstanding record of general management, sales and marketing accomplishments, signals our commitment to move our unique technologies to market more rapidly," Erwin said in a statement.

 

This is Ryan's second term as an executive at LSBC. He served as president of the company from 1991 to 1995, and then left to become CEO of contact lens manufacturer Wesley Jessen Corporation.

 

In another management change, Ronald Artale, LSBC's senior vice president and chief financial officer will also take on the position of chief operating officer.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.